Published Mon, 03 Dec 2018 13:45:10 -0500 on Seeking Alpha
Actionable Conclusions (1-10): Brokers Forecast Ten High Yield Top Healthcare 'Safer' Dividend Stocks to Net 12.6% to 26.75% Gains To November 2019
Four of ten top 'safer' dividend Healthcare stocks by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year. Thus, based on analyst 1-year target prices, the dog strategy for this Health group graded out as 40% accurate.
Projections based on estimated dividends from $1,000 invested in the ten highest yielding Healthcare stocks, and aggregate one-year analyst mean target prices for tho stocks, as reported by YCharts, created the 2019 data points. Note: one-year target prices from one analyst were not applied (n/a). Ten probable profit-generating trades to 2019 were:
Gilead Sciences (GILD) netted $267.47 based on estimates from twenty-seven analysts, plus dividends less broker fees. The Beta number showed this estimate subject to volatility 1% more than the market as a whole.
Fresenius Medical Care (FMS) netted $196.12 based on dividends plus median target price estimate from six analysts less broker fees. The Beta number 11% over the market as a whole.
Bristol-Myers Squibb Co (BMY) netted $173.08 based on estimates from eighteen analysts, plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 8% more than the market as a whole.
Zimmer Biomet Holdings (ZBH) netted $167.10 based on a median target... Read more
|Stock name||Last trade||P/E||Earnings/Share||Dividend/Share||Dividend yield|
|JOHNSON & JOHNSON||130.43||21.6||6.03||3.80||2.93|
|FRESENIUS MEDICAL CARE||34.62||15.0||2.30||0.45||1.29|
Older articles featuring Abbvie (ABBV):DGI For The DIY: Q3 2020 Dividend Portfolio Update
December Dividend Aristocrats Savor 6 Super Stocks
November Buys: 3 Monthly Paying CEFs, Plus Some Dividend Growth Opportunities
Ride Through Another COVID Wave With These 5 Undervalued Dividend Growth Stocks
4 Buffett Fat Pitch High-Yield Blue-Chip Bargains Set To Soar
Nicholas Ward's Dividend Growth Portfolio: November 2020 Review
Dividend Income Summary: Lanny's November 2020 Summary
My Dividend Growth Portfolio November Review: 32 Holdings, 1 Buy
All Weather Dividends: 10 Value Buys And 5 Overvalued Sells To End 2020
A Dividend Cornucopia Of 39 November Kiplinger/Analyst Favorites